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INVITED COMMENTARYDoes Standardised Post-CEA Blood Pressure Control Make Cerebral
Monitoring for Hyperperfusion Irrelevant?
G.J. de Borst *, F.L. Moll
Department of Vascular Surgery, University Medical Center Utrecht, G04.129, P.O. Box 85500, 3508 GA Utrecht, The NetherlandsIdentiﬁcation of patients at risk for developing cerebral
hyperperfusion syndrome (HS) following carotid endarterec-
tomy (CEA) is essential, as treatment in the early phase can
potentially prevent life-threatening symptoms. Previous
studies have shown the ability of perioperative transcranial
Doppler (TCD) to more accurately predict occurrence of HS
and associated intracranial haemorrhage (ICH) or stroke.1,2
Based on these studies, Newman et al. retrospectively ana-
lysed 1450 CEA patients with accessible TCD window.3 The
authors were unable to demonstrate that increases in middle
cerebral artery velocity predicted risk of suffering post-
operative stroke due to HS. This observation however may
have been severely inﬂuenced by the study design applied.
While previous studies were ‘observational’ in design
(with blood pressure (BP) intervention on indication), New-
man performed an ‘intervention study’ providing a one-size-
ﬁts-all written guidance on treating hypertension in the
immediate postoperative phase in ‘all’ patients (group 2;
N ¼ 426). Possibly due to its retrospective character, this
study did inform neither on the applied treatment in group 1
(N¼ 1024) patients with presence of>100% increase nor on
the actual applied therapy in the small number of cases that
got ICH/HS. In group 2, BP-lowering treatment focussed on
an absolute threshold (target <160 mmHg) with the inten-
tion to “treat any persisting hypertension post-operatively
before discharge”. In this group no postoperative ICH/HS
was observed. It might indeed well be true that uniform BP-
lowering therapy in all CEA patients will prevent most
hyperperfusion-related sequelae, but it is premature to
conclude so based on the data provided. Of relevance, this
study only provides indirect evidence on the role of TCD in
HS prediction, as the applied intervention (BP < 160 mmHg
in all patients) may have completely masked the occurrence
of HS. The short title of this paper therefore better reﬂects
the focus and value of this study than the main title.
Furthermore, it should be reconﬁrmed that even though
the BP protocol succeeded in the case series presented
(as no one with a BP < 160 mmHg suffered an ICH or HS
stroke), it is well known that HS does may occur in patients
with postoperative BP < 160 mmHg. A protocol to keep
every patient below 160 mmHg does not guarantee thatDOI of original article: http://dx.doi.org/10.1016/j.ejvs.2013.02.019
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In the authors’ centre, patients who exhibited (ongoing)
signs of HS despite normotension further BP lowering was
applied till symptoms resolved. However, HS may occur
post-discharge up to 4 weeks after CEA when clinical signs
of HS may not immediately be recognised. This aspect was
more or less reﬂected in Group 1, as three out of seven ICHs
occurred after discharge.
Of note, in this analysis less than half the patients in both
time frames actually received TCD monitoring in the
recovery phase (Table 5), while our recent work has shown
that TCD to predict CHS (including those with ICH þ stroke)
is especially valuable when performed in the awake post-
operative phase.2
It should be clear to the reader of the journal that it may
take signiﬁcant effort (invasive monitoring, extended hospi-
talisation and higher costs) to achieve stable BP< 160 mmHg
before discharge, especially in CEA patients. While identiﬁ-
cation of those at high risk for HS is highly relevant, it is of
major importance for both the individual patient and hospital
infrastructure to reliably select patients ‘without any risk’ for
HS. The negative predictive value (NPV) of TCD in the New-
man study was shown high, as in our study (NPV >99%), and
this should be better highlighted. These patients may need BP
lowering on the longer term but not as urgently while still in
hospital. Peri-operative identiﬁcation of those ‘not’ at risk for
HS will lead to fewer patients being treated unnecessarily by
strict (intravenous) anti-hypertensive medication.2
In conclusion, a standardised BP regimen applied to all
CEA patients can never abolish HS-related stroke, and
cannot per se replace perioperative cerebral monitoring to
identify those patients at high but especially low risk for
hyperperfusion syndrome.REFERENCES
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